Studies Directed Toward the Synthesis of Crambescidin 816
Crambescidin 816 合成研究
基本信息
- 批准号:7409301
- 负责人:
- 金额:$ 3.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2008-09-30
- 项目状态:已结题
- 来源:
- 关键词:AlkaloidsAntiviral AgentsBehaviorBiologicalBiological TestingCarbodiimidesCarbonCaribbean nativesCaribbean regionClassColon CarcinomaCrambe crambeElectronsHerpesvirus 1HumanHydroxyl RadicalMalignant Epithelial CellMasksPoriferaPositioning AttributePyrrolesRangeRouteSimplexvirusStagingStructure-Activity RelationshipUrsidae Familycrambescidin 816cycloadditionguanidiniumhydroxyl group
项目摘要
DESCRIPTION (provided by applicant): Proposed are studies directed toward the synthesis of the pentacyclic guanidinium alkaloid crambescidin 816, the major constituent of the extracts of the red Caribbean sponge Crambe crambe. Crambescidin 816 displays a range of potentially significant biological activities including strong inhibition of the herpes simplex virus HSV-1, high activity against HCT-16 human colon carcinoma cells, and Ca++ antagonist behavior. However, the synthesis of crambescidin 816 has not been realized, due in large part to difficulty in installing the C13 hydroxyl group. The proposed approach to the synthesis of crambescidin 816 has, as its focal point, the highly diastereoselective [4+2] cycloaddition between an electron-deficient alkenyl carbodiimide and a chiral, 3,4-dihydro-2H-pyrrole that bears functionality at the imidoyl carbon atom. This approach allows for ready installation of masked hydroxyl functionality at what will become the C13 position of crambescidin 816 that can be revealed in a late stage of the synthesis. The long-term objectives of the proposed activities are to develop an efficient and flexible synthetic plan that will provide sufficient quantities of crambescidin 816 for thorough biological testing, will allow for the synthesis of related derivatives for the determination of structure-activity relationships, and that will be applicable to the synthesis of a range of guanidinium alkaloids such as crambescidins 830 and 844. Crambescidin 816 is the major constituent of the extracts of the red Caribbean sponge Crambe crambe and displays a range of potentially significant biological activities including antitumor and antiviral activity. The proposed studies will develop efficient and flexible synthetic routes that will provide sufficient quantities of crambescidin 816 for thorough biological testing, that will facilitate the synthesis of related biologically active molecules, and that will allow the structure-activity relationships of this important class of molecules to be investigated.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROSS A WIDENHOEFER其他文献
ROSS A WIDENHOEFER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROSS A WIDENHOEFER', 18)}}的其他基金
Catalytic Hydrofunctionalization as a Route to Heterocyclic Compounds
催化氢官能化作为杂环化合物的途径
- 批准号:
7246304 - 财政年份:2007
- 资助金额:
$ 3.76万 - 项目类别:
Catalytic Hydrofunctionalization as a Route to Heterocyclic Compounds
催化氢官能化作为杂环化合物的途径
- 批准号:
7680801 - 财政年份:2007
- 资助金额:
$ 3.76万 - 项目类别:
Catalytic Hydrofunctionalization as a Route to Heterocyclic Compounds
催化氢官能化作为杂环化合物的途径
- 批准号:
7681655 - 财政年份:2007
- 资助金额:
$ 3.76万 - 项目类别:
Catalytic Hydrofunctionalization as a Route to Heterocyclic Compounds
催化氢官能化作为杂环化合物的途径
- 批准号:
7491199 - 财政年份:2007
- 资助金额:
$ 3.76万 - 项目类别:
PALLADIUM CATALYZED CYCLIZATION OF FUNCTIONALIZED DIENES
钯催化官能化二烯的环化
- 批准号:
6386592 - 财政年份:1999
- 资助金额:
$ 3.76万 - 项目类别:
PALLADIUM CATALYZED CYCLIZATION OF FUNCTIONALIZED DIENES
钯催化官能化二烯的环化
- 批准号:
2885794 - 财政年份:1999
- 资助金额:
$ 3.76万 - 项目类别:
PALLADIUM CATALYZED CYCLIZATION OF FUNCTIONALIZED DIENES
钯催化官能化二烯的环化
- 批准号:
6182147 - 财政年份:1999
- 资助金额:
$ 3.76万 - 项目类别:
PALLADIUM CATALYZED CYCLIZATION OF FUNCTIONALIZED DIENES
钯催化官能化二烯的环化
- 批准号:
6526155 - 财政年份:1999
- 资助金额:
$ 3.76万 - 项目类别:
PALLADIUM CATALYZED CYCLIZATION OF FUNCTIONALIZED DIENES
钯催化官能化二烯的环化
- 批准号:
6655618 - 财政年份:1999
- 资助金额:
$ 3.76万 - 项目类别:
相似国自然基金
核苷类抗病毒药物嵌合型核酸纳米载体的构筑及其抗病毒性能研究
- 批准号:52303174
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水环境中抗病毒药物及其转化副产物的识别及生态毒性效应研究
- 批准号:52300245
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向病毒核衣壳蛋白质相分离的抗病毒药物发现及机制研究
- 批准号:82302491
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
天然/合成有机质结合态抗病毒药物的迁移特性和界面行为
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
分区耦合式三电子氧还原高级氧化系统处理核苷类抗病毒药物废水及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Synthetic Biology Platforms for Natural Product Discovery and Biosynthesis
用于天然产物发现和生物合成的合成生物学平台
- 批准号:
8719021 - 财政年份:2012
- 资助金额:
$ 3.76万 - 项目类别:
Novel Approaches for Antitumor and Antiviral Agents
抗肿瘤和抗病毒药物的新方法
- 批准号:
7922688 - 财政年份:1987
- 资助金额:
$ 3.76万 - 项目类别:
Novel Approaches for Antitumor and Antiviral Agents
抗肿瘤和抗病毒药物的新方法
- 批准号:
8135195 - 财政年份:1987
- 资助金额:
$ 3.76万 - 项目类别:
Novel Approaches for Antitumor and Antiviral Agents
抗肿瘤和抗病毒药物的新方法
- 批准号:
7652559 - 财政年份:1987
- 资助金额:
$ 3.76万 - 项目类别:
Novel Approaches for Antitumor and Antiviral Agents
抗肿瘤和抗病毒药物的新方法
- 批准号:
8318840 - 财政年份:1987
- 资助金额:
$ 3.76万 - 项目类别: